Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.5K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.5K
Seizures: Classification01:13

Seizures: Classification

1.9K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An open-label, single-arm, dose-escalating concentration-QT study to investigate the cardiac effects and safety of paroxetine in healthy adults.

British journal of clinical pharmacology·2026
Same author

Evaluation of the Effect of Clobetasol Propionate on Circulating Cortisol and Growth Velocity in Children with Atopic Dermatitis: A Modelling and Simulation Study.

Dermatology (Basel, Switzerland)·2025
Same author

Cefuroxime axetil dosing regimens and probability of target attainment in adults and children.

British journal of clinical pharmacology·2025
Same author

Item Response Modeling and Artificial Neural Network for Differentiation of Parkinson's Patients and Subjects Without Evidence of Dopaminergic Deficit.

CPT: pharmacometrics & systems pharmacology·2025
Same author

Spontaneous spreading depolarizations originate subcortically in a novel mouse model of familial hemiplegic migraine type 2.

Neurobiology of disease·2024
Same author

Study APV20002: Safety and Efficacy Results Through Week 684 for Pediatric Participants Living with HIV-1 Treated with Ritonavir-Boosted Fosamprenavir Oral Solution-Based Antiretroviral Therapy.

AIDS research and human retroviruses·2024

Related Experiment Video

Updated: Mar 2, 2026

Author Spotlight: Obtaining High-Quality CSF and Blood Samples for Epilepsy Biomarker Discovery
10:46

Author Spotlight: Obtaining High-Quality CSF and Blood Samples for Epilepsy Biomarker Discovery

Published on: September 1, 2023

4.5K

Biomarkers in epilepsy-A modelling perspective.

Sven C van Dijkman1, Rob A Voskuyl1, Elizabeth C de Lange1

  • 1Division of Pharmacology, Leiden Academic Centre for Drug Research, The Netherlands.

European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|May 22, 2017
PubMed
Summary
This summary is machine-generated.

This study categorizes epilepsy biomarkers and identifies gaps, particularly in target occupancy and activation. Filling these gaps is crucial for developing mathematical models to personalize anti-epileptic drug treatments.

Keywords:
BiomarkersDisease progressionIndividualised medicinePersonalised medicinePhysiology-based modelsSystems biologySystems pharmacology

More Related Videos

Statistical Modelling of Cortical Connectivity Using Non-invasive Electroencephalograms
08:51

Statistical Modelling of Cortical Connectivity Using Non-invasive Electroencephalograms

Published on: November 1, 2019

6.1K
Brain Source Imaging in Preclinical Rat Models of Focal Epilepsy using High-Resolution EEG Recordings
08:20

Brain Source Imaging in Preclinical Rat Models of Focal Epilepsy using High-Resolution EEG Recordings

Published on: June 6, 2015

16.0K

Related Experiment Videos

Last Updated: Mar 2, 2026

Author Spotlight: Obtaining High-Quality CSF and Blood Samples for Epilepsy Biomarker Discovery
10:46

Author Spotlight: Obtaining High-Quality CSF and Blood Samples for Epilepsy Biomarker Discovery

Published on: September 1, 2023

4.5K
Statistical Modelling of Cortical Connectivity Using Non-invasive Electroencephalograms
08:51

Statistical Modelling of Cortical Connectivity Using Non-invasive Electroencephalograms

Published on: November 1, 2019

6.1K
Brain Source Imaging in Preclinical Rat Models of Focal Epilepsy using High-Resolution EEG Recordings
08:20

Brain Source Imaging in Preclinical Rat Models of Focal Epilepsy using High-Resolution EEG Recordings

Published on: June 6, 2015

16.0K

Area of Science:

  • Biomarker research
  • Systems biology
  • Systems pharmacology

Background:

  • Biomarkers are classified into types 0-6, representing biological processes and drug treatment stages.
  • Existing reviews cover epilepsy biomarkers but lack integration strategies for personalized medicine.
  • A significant gap exists in quantitative biomarkers for understanding disease and treatment dynamics.

Purpose of the Study:

  • To categorize available epilepsy biomarkers and identify knowledge gaps.
  • To propose a modeling perspective for addressing these biomarker gaps.
  • To facilitate the integration of biomarkers for personalized anti-epileptic drug therapy.

Main Methods:

  • Review and categorization of existing epilepsy biomarkers based on a type 0-6 classification.
  • Identification of specific biomarker types (e.g., target occupancy, target activation) that are currently lacking.
  • Conceptual framework for integrating diverse biomarker data for mathematical modeling.

Main Results:

  • Epilepsy biomarker research primarily focuses on qualitative diagnostic and predictive markers.
  • A notable deficiency exists in quantitative biomarkers, specifically type 2 (target occupancy) and type 3 (target activation).
  • The integration of current biomarkers is insufficient for comprehensive mathematical modeling of epilepsy and its treatment.

Conclusions:

  • Personalized anti-epileptic drug treatment requires a more integrated approach using diverse biomarker types.
  • Addressing biomarker gaps, especially in target engagement, is essential for advancing systems pharmacology in epilepsy.
  • Interdisciplinary collaboration between systems biology and systems pharmacology is vital for future progress.